Srinagar: The Apollo Hospitals Enterprise Limited is proud to announce its partnership with Mobile ODT that will apply its Enhanced Visual Assessment (EVA) System to reduce the loss of follow-up for women who screen positive on cervical cancer screening tests, and increase internal capacity to screen for cervical cancer at a lower cost.
Cervical cancer kills 1 Indian every 7 minutes and more women die from cervical cancer in India, than in any other country and it is preventable. However, to be effective in reducing cervical cancer incidence and mortality, screening programs must be of high quality. Mobile ODTs Enhanced Visual Assessment (EVA) System, is a comprehensive point of care tool, built on a smartphone, for cervical cancer screening. The device augments a smartphones optics to enable enhanced imaging while the app allows for image and patient data capture for remote consultation.
Apollo Research and Innovations (ARI), a division of Apollo Hospitals has a comprehensive ecosystem to undertake evaluation and validation of Innovations in Healthcare. With the burden of cervical cancer, it is important to have clarity on cervical cancer screening to get information and actual data from the rural, semi-urban and urban areas to get the realistic community data and perspective.
Seemant Jauhari, CEO – Research & Innovations, Apollo Hospitals said, The Indian healthcare landscape presents significant challenges related to patient volumes access and affordability. Traditional healthcare delivery models necessarily need to be disrupted by converging Technology with healthcare. Mobile ODT is one such disruptive technology which shall facilitate taking cervical screening to the people of India, enable early screening and hence early treatment thus slowing down incidences of cervical cancer. It maximizes the chances of making cervical cancer screening program successful.
“India is home to 1/3 of all cervical cancer deaths worldwide. We are honoured to be working with Apollo Hospitals given its focus on quality, innovative, and patient centred care to tackle this large, but preventable challenge women face across all of India. We hope this partnership continues to expand, to ensure all Apollo patients have quality cervical cancer screening from the smallest rural clinic and telemedicine efforts to the large urban centres.” said Ariel Beery, CEO, Mobile ODT.
Mobile ODT EVA system has been piloted around the world (namely in Haiti, Guatemala, Botswana, Kenya, Nepal, Mexico, Kenya, United States) before the collaboration with Apollo Hospitals. It is important to pilot the device over 5 sites to understand the efficacy, utility and usability of the technology. The sites chosen cover rural area (Aragonda), semi-urban (Apollo Vanagaram, Apollo Madurai), urban (Apollo First Med, Apollo Tondiarpet) and high-income group (Bangalore). With the presence of Apollo Hospital centres in all the areas, Apollo Research and Innovations (ARI) is in a position to give the public data, rather than restricting to only a regional data.
Apollo Hospitals Enterprise Limited with Mobile ODT was selected from 330 companies to apply the life-saving technology in India through Tech Emerge, which matches technology companies around the world with partners in emerging markets to deliver tools that improve the quality of life. As a result of the rigorous process, with advisors from IFC and Health 2.0 part of the design, MobileODT is launching new pilots with Apollo Hospitals and International Oncology.
Follow this link to join our WhatsApp group: Join Now
Be Part of Quality Journalism |
Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast. |
| ACT NOW |
| MONTHLY | Rs 100 |  |
| YEARLY | Rs 1000 | |
| LIFETIME | Rs 10000 | |
